CORO1A report

Query

Invalid input gene. Please select from the suggestions.

I. Expression across cell types

Cell ontologyData table

Name	Number of supported studies	Average coverage
natural killer cell	47 studies	67% ± 23%	Explore
B cell	46 studies	63% ± 22%	Explore
CD8-positive, alpha-beta T cell	41 studies	69% ± 22%	Explore
T cell	38 studies	61% ± 26%	Explore
CD4-positive, alpha-beta T cell	35 studies	70% ± 22%	Explore
conventional dendritic cell	28 studies	73% ± 20%	Explore
regulatory T cell	28 studies	76% ± 17%	Explore
classical monocyte	27 studies	69% ± 19%	Explore
macrophage	26 studies	42% ± 18%	Explore
non-classical monocyte	25 studies	78% ± 21%	Explore
plasmacytoid dendritic cell	25 studies	73% ± 16%	Explore
mature NK T cell	22 studies	71% ± 17%	Explore
monocyte	21 studies	63% ± 23%	Explore
dendritic cell	20 studies	62% ± 28%	Explore
memory B cell	20 studies	75% ± 13%	Explore
naive B cell	20 studies	65% ± 15%	Explore
gamma-delta T cell	19 studies	72% ± 17%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	18 studies	66% ± 18%	Explore
mucosal invariant T cell	16 studies	71% ± 17%	Explore
CD16-positive, CD56-dim natural killer cell, human	16 studies	74% ± 20%	Explore
CD16-negative, CD56-bright natural killer cell, human	15 studies	74% ± 18%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	15 studies	74% ± 21%	Explore
CD8-positive, alpha-beta memory T cell	13 studies	68% ± 23%	Explore
myeloid cell	13 studies	51% ± 20%	Explore
effector memory CD8-positive, alpha-beta T cell	12 studies	64% ± 20%	Explore
plasma cell	12 studies	53% ± 20%	Explore
CD4-positive, alpha-beta memory T cell	12 studies	67% ± 22%	Explore
neutrophil	12 studies	56% ± 23%	Explore
innate lymphoid cell	11 studies	53% ± 20%	Explore
plasmablast	11 studies	67% ± 20%	Explore
T follicular helper cell	10 studies	66% ± 14%	Explore
leukocyte	10 studies	47% ± 23%	Explore
effector CD8-positive, alpha-beta T cell	8 studies	74% ± 25%	Explore
mast cell	8 studies	25% ± 17%	Explore
CD4-positive helper T cell	6 studies	51% ± 17%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	6 studies	65% ± 24%	Explore
hematopoietic precursor cell	6 studies	52% ± 23%	Explore
platelet	6 studies	38% ± 20%	Explore
effector CD4-positive, alpha-beta T cell	6 studies	77% ± 29%	Explore
precursor B cell	6 studies	60% ± 24%	Explore
microglial cell	6 studies	40% ± 24%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	74% ± 18%	Explore
central memory CD8-positive, alpha-beta T cell	5 studies	67% ± 13%	Explore
exhausted T cell	5 studies	91% ± 7%	Explore
mononuclear phagocyte	5 studies	53% ± 26%	Explore
hematopoietic stem cell	5 studies	37% ± 13%	Explore
T-helper 17 cell	5 studies	81% ± 14%	Explore
group 3 innate lymphoid cell	5 studies	75% ± 14%	Explore
immature B cell	5 studies	89% ± 7%	Explore
double negative thymocyte	5 studies	81% ± 7%	Explore
intermediate monocyte	5 studies	78% ± 16%	Explore
CD4-positive, alpha-beta cytotoxic T cell	4 studies	69% ± 26%	Explore
lymphocyte	4 studies	45% ± 27%	Explore
pro-B cell	4 studies	47% ± 6%	Explore
germinal center B cell	4 studies	88% ± 7%	Explore
granulocyte	4 studies	42% ± 19%	Explore
T-helper 1 cell	4 studies	84% ± 12%	Explore
erythrocyte	4 studies	45% ± 17%	Explore
thymocyte	3 studies	45% ± 29%	Explore
common myeloid progenitor	3 studies	46% ± 21%	Explore
follicular B cell	3 studies	65% ± 17%	Explore
intraepithelial lymphocyte	3 studies	84% ± 3%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	80% ± 9%	Explore
double-positive, alpha-beta thymocyte	3 studies	87% ± 5%	Explore

II. Expression across tissues

sc-RNAseq dataData table

Name	Number of supported studies	Average coverage
peripheral blood	21 studies	68% ± 21%	Explore
lung	10 studies	31% ± 13%	Explore
bone marrow	6 studies	36% ± 21%	Explore
intestine	5 studies	30% ± 9%	Explore
kidney	5 studies	37% ± 25%	Explore
lymph node	5 studies	57% ± 17%	Explore
brain	4 studies	33% ± 21%	Explore
liver	3 studies	53% ± 17%	Explore

Bulk RNAseq dataData table

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	4841.18	577 / 578	95%	40.07	1095 / 1155
brain	95%	2316.18	2504 / 2642	99%	45.86	701 / 705
stomach	85%	1257.14	304 / 359	92%	38.29	262 / 286
intestine	84%	3552.74	811 / 966	91%	38.61	480 / 527
breast	83%	1042.61	380 / 459	91%	35.16	1015 / 1118
uterus	78%	853.56	132 / 170	94%	35.51	430 / 459
bladder	81%	1499.19	17 / 21	85%	40.03	430 / 504
thymus	79%	1399.21	515 / 653	85%	78.53	516 / 605
prostate	83%	1249.26	203 / 245	65%	13.17	325 / 502
adrenal gland	91%	1411.26	235 / 258	54%	10.20	125 / 230
esophagus	63%	800.43	914 / 1445	79%	17.67	145 / 183
kidney	55%	1036.87	49 / 89	87%	33.16	785 / 901
skin	55%	523.29	1000 / 1809	83%	54.82	390 / 472
ovary	41%	420.00	74 / 180	85%	23.39	366 / 430
pancreas	27%	287.13	89 / 328	92%	42.74	164 / 178
liver	58%	603.88	131 / 226	56%	15.78	229 / 406
lymph node	0%	0	0 / 0	100%	968.14	29 / 29
peripheral blood	100%	59241.73	929 / 929	0%	0	0 / 0
spleen	100%	30962.11	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	96%	78.70	43 / 45
adipose	95%	1921.14	1146 / 1204	0%	0	0 / 0
blood vessel	63%	1108.93	838 / 1335	0%	0	0 / 0
heart	36%	371.42	314 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	30%	8.36	24 / 80
muscle	2%	11.47	13 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1